Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
NelnetOscar Health

Nelnet vs Oscar Health

Nelnet Inc and Oscar Health, Inc. This page compares their business models, financial performance, and market context, presenting neutral, accessible information for readers seeking understanding. Edu...

Investment Analysis

Pros

  • Nelnet reported strong first quarter 2025 earnings, with net income excluding derivative adjustments up 29.7% year-on-year.
  • The company maintains a diversified business model across loan servicing, education technology, and financial services, supporting stable revenue streams.
  • Nelnet has enhanced its capital and liquidity positions, providing flexibility for strategic investments and resilience in uncertain markets.

Considerations

  • The stock is trading at a significant premium to some discounted cash flow fair value estimates, suggesting potential overvaluation risks.
  • Nelnet's debt-to-equity ratio remains high, which could constrain financial flexibility if interest rates rise further.
  • The company's performance is sensitive to changes in student loan policies and broader economic conditions affecting loan demand.

Pros

  • Oscar Health has raised its full-year 2025 revenue outlook, indicating strong growth momentum in its core insurance business.
  • The company delivered better-than-expected Q1 2025 earnings, beating consensus EPS and revenue estimates.
  • Oscar Health continues to expand its customer base and market presence, supported by increasing demand for digital health solutions.

Considerations

  • Oscar Health reported a significant net loss in Q2 2025, reflecting ongoing profitability challenges in the competitive health insurance sector.
  • The company's share price is highly volatile, with a beta above 1.8, increasing risk for investors during market downturns.
  • Oscar Health faces regulatory and legal risks, including lawsuits over Affordable Care Act rules that could impact future operations.

Buy NNI or OSCR in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

NelnetLazard

Nelnet vs Lazard

Nelnet vs Lazard: business comparison

NelnetRadian

Nelnet vs Radian

Nelnet vs Radian: comparing two groups

NelnetLemonade

Nelnet vs Lemonade

Nelnet vs Lemonade: a neutral comparison

Frequently asked questions